Association of cumulatively low or high serum calcium levels with mortality in long-term hemodialysis patients

American Journal of Nephrology

Volumn 32, Issue 5, 2010, Pages 403-413

  Miller, Jessica E ^a,c   Kovesdy, Csaba P ^e   Norris, Keith C ^d   Mehrotra, Rajnish ^a,b   Nissenson, Allen R ^b,f   Kopple, Joel D ^a,b,c   Kalantar Zadeh, Kamyar ^a,b,c  

^a UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f DAVITA INC   (United States)

Author keywords

Chronic kidney disease; Hypercalcemia; Hyperparathyroidism; Hypocalcemia; Mineral and bone disorder; Paricalcitol; Phosphorus; Racial disparities

Indexed keywords

BICARBONATE; CALCIMIMETIC AGENT; CALCIUM; CREATININE; FERRITIN; HEMOGLOBIN; PARATHYROID HORMONE; PARICALCITOL; PHOSPHORUS;

ADULT; AGED; ARTICLE; BICARBONATE BLOOD LEVEL; CALCIUM BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIALYSATE; FEMALE; FERRITIN BLOOD LEVEL; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HISPANIC; HUMAN; HYPERCALCEMIA; HYPOCALCEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PREDICTION; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; SURVIVAL;

ADULT; AFRICAN AMERICANS; AGED; BONE DENSITY CONSERVATION AGENTS; CAUSE OF DEATH; ERGOCALCIFEROLS; FEMALE; HUMANS; HYPERCALCEMIA; HYPOCALCEMIA; KIDNEY FAILURE, CHRONIC; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PARATHYROID HORMONE; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; TIME FACTORS;

EID: 77956115913     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000319861     Document Type: Article

References (54)

1. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004;15:2208-2218.
2. Kalantar-Zadeh K, Kuwae N, Regidor DL, Kovesdy CP, Kilpatrick RD, Shinaberger CS, McAllister CJ, Budoff MJ, Salusky IB, Kopple JD: Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 2006;70:771-780.
3. Stevens LA, Li S, Wang C, Huang C, Becker BN, Bomback AS, Brown WW, Burrows NR, Jurkovitz CT, McFarlane SI, Norris KC, Shlipak M, Whaley-Connell AT, Chen SC, Bakris GL, McCullough PA: Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 2010;55: S23-S33.
4. National Kidney Foundation I, Kidney Disease-Dialysis Outcome Quality Initiative: K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003;42: S1-S202.
5. Uhlig K, Berns JS, Kestenbaum B, Kumar R, Leonard MB, Martin KJ, Sprague SM, Goldfarb S: KDOQI US commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD). Am J Kidney Dis 2010;55:773-799.
6. Kalantar-Zadeh K, Miller JE, Kovesdy CP, Mehrotra R, Lukowski LR, Streja E, Ricks J, Jing J, Nissenson AR, Greenland S, Norris KC: Impact of race on hyperparat hyroidism, mineral disarrays, administered vitamin D and survival in hemodialysis patients. J Bone Miner Res 2010, E-pub ahead of print.
7. Kalantar-Zadeh K, Shah A, Duong U, Hechter RC, Dukkipati R, Kovesdy CP: Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, alkaline phosphatase and minerals. Kidney Int Suppl 2010, in press.
8. Schwarz S, Trivedi BK, Kalantar-Zadeh K, Kovesdy CP: Association of disorders in mineral metabolism with progression of chronic kidney disease. Clin J Am Soc Neph 2006;1:825-831.
9. Kovesdy CP, Kuchmak O, Lu JL, Kalantar-Zadeh K: Outcomes associated with serum calcium level in men with non-dialysis-dependent chronic kidney disease. Clin J Am Soc Nephrol 2010;5:468-476.
10. Zivin JR, Gooley T, Zager RA, Ryan MJ: Hypocalcemia: a pervasive metabolic abnormality in the critically ill. Am J Kidney Dis 2001;37:689-698.
11. Lowrie EG, Lew NL: Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990;15:458-482.
12. Wald R, Sarnak MJ, Tighiouart H, Cheung AK, Levey AS, Eknoyan G, Miskulin DC: Disordered mineral metabolism in hemodialysis patients: an analysis of cumulative effects in the Hemodialysis (HEMO) Study. Am J Kidney Dis 2008;52:531-540.
13. Tentori F, Blayney MJ, Albert JM, Gillespie BW, Kerr PG, Bommer J, Young EW, Akizawa T, Akiba T, Pisoni RL, Robinson BM, Port FK: Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2008;52:519-530.
14. Melamed ML, Eustace JA, Plantinga L, Jaar BG, Fink NE, Coresh J, Klag MJ, Powe NR: Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study. Kidney Int 2006;70:351-357.
15. Shinaberger CS, Kopple JD, Kovesdy CP, McAllister CJ, van Wyck D, Greenland S, Kalantar-Zadeh K: Ratio of paricalcitol dosage to serum parathyroid hormone level and survival in maintenance hemodialysis patients. Clin J Am Soc Nephrol 2008;3:1769-1776.
16. Mochizuki T, Naganuma S, Tanaka Y, Iwamoto Y, Ishiguro C, Kawashima Y, Maekawa K, Suda A, Akiba T: Prospective comparison of the effects of maxacalcitol and calcitriol in chronic hemodialysis patients with secondary hyperparathyroidism: a multicenter, randomized crossover study. Clin Nephrol 2007;67:12-19.
17. Kalantar-Zadeh K, Kovesdy CP: Clinical outcomes with active versus nutritional vitamin D compounds in chronic kidney disease. Clin J Am Soc Nephrol 2009;4:1529-1539.
18. Kovesdy CP, Mehrotra R, Kalantar-Zadeh K: Battleground: chronic kidney disorders mineral and bone disease - calcium obsession, vitamin D, and binder confusion. Clin J Am Soc Nephrol 2008;3:168-173.
19. Kalantar-Zadeh K, Lee GH, Miller JE, Streja E, Jing J, Robertson JA, Kovesdy CP: Predictors of hyporesponsiveness to erythropoiesis-stimulating agents in hemodialysis patients. Am J Kidney Dis 2009;53:823-834.
20. Kalantar-Zadeh K, Regidor DL, Kovesdy CP, Van Wyck D, Bunnapradist S, Horwich TB, Fonarow GC: Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis. Circulation 2009;119:671-679.
21. Regidor DL, Kovesdy CP, Mehrotra R, Rambod M, Jing J, McAllister CJ, Van Wyck D, Kopple JD, Kalantar-Zadeh K: Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients. J Am Soc Nephrol 2008;19:2193-2203.
22. Shinaberger CS, Greenland S, Kopple JD, Van Wyck D, Mehrotra R, Kovesdy CP, Kalantar-Zadeh K: Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease? Am J Clin Nutr 2008;88:1511-1518.
23. Miller JE, Kovesdy CP, Nissenson AR, Mehrotra R, Streja E, Van Wyck D, Greenland S, Kalantar-Zadeh K: Association of hemodialysis treatment time and dose with mortality and the role of race and sex. Am J Kidney Dis 2010;55:100-112.
24. Longenecker JC, Coresh J, Klag MJ, Levey AS, Martin AA, Fink NE, Powe NR: Validat ion of comorbid condit ions on the end-stage renal disease medical evidence report: the CHOICE study. Choices for Healthy Outcomes in Caring for ESRD. J Am Soc Nephrol 2000;11:520-529.
25. McKane W, Chandna SM, Tattersall JE, Greenwood RN, Farrington K: Identical decline of residual renal function in high-flux biocompatible hemodialysis and CAPD. Kidney Int 2002;61:256-265.
26. Kalantar-Zadeh K, Kovesdy CP: Is it worth correcting hyperparathyroidism if hyperphosphatemia and hypocalcemia worsen? A cinaca lcet story. Am J Kidney Dis 2009;53:183-188.
27. Belozeroff V, Goodman WG, Ren L, Kalantar-Zadeh K: Cinacalcet lowers serum alkaline phosphatase in maintenance hemodialysis patients. Clin J Am Soc Nephrol 2009;4:673-679.
28. Shantouf RS, Budoff MJ, Ahmadi N, Ghaffari A, Flores F, Gopal A, Noori N, Jing J, Kovesdy CP, Kalantar-Zadeh K: Total and individual coronary artery calcium scores as independent predictors of mortality in hemodialysis patients. Am J Nephrol 2010;31:419-425.
29. Braun J, Oldendorf M, Moshage W, Heidler R, Zeitler E, Luft FC: Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 1996;27:394-401.
30. Kurz P, Monier-Faugere MC, Bognar B, Werner E, Roth P, Vlachojannis J, Malluche HH: Evidence for abnormal calcium homeostasis in patients with adyna mic bone disease. Kidney Int 1994;46:855-861.
31. Fournier A, Yverneau PH, Hue P, Said S, Hamdini N, Eldin HM, Mohageb S, Oprisiu R, Marie A, Solal ME, et al: Adynamic bone disease in patients with uremia. Curr Opin Nephrol Hy pertens 1994;3:396-410.
32. Andress DL: Adynamic bone in patients with chronic kidney disease. Kidney Int 2008;73:1345-1354.
33. Bleyer AJ, Choi M, Igwemezie B, de la Torre E, White WL: A case control study of proximal calciphylaxis. Am J Kidney Dis 1998;32:376-383.
34. Merrill JP, Hampers CL: Uremia. II. N Engl J Med 1970;282:1014-1021.
35. Collier VU, Mitch WE: Accelerated progression of chronic renal insufficiency after parathyroidectomy. JAMA 1980;244:1215-1218.
36. Kovesdy CP: Survival benefits with vitamin D receptor activation: new insights since 2003. Clin J Am Soc Nephrol 2010, Epub ahead of print.
37. Shantouf R, Budoff MJ, Ahmadi N, Tiano J, Flores F, Kalantar-Zadeh K: Effects of sevelamer and calcium-based phosphate binders on lipid and inflammatory markers in hemodialysis patients. Am J Nephrol 2008;28:275-279.
38. Sha ntouf R, Ahmad i N, Flores F, Tiano J, Gopal A, Kalantar-Zadeh K, Budoff MJ: Impact of phosphate binder type on coronary artery calcification in hemodialysis patients. Clin Nephrol 2010;74:12-18.
39. Andress DL: Lower target calcium levels in dialysis patients. Semin Dial 2002;15:74.
40. Slatopolsky E, Gon zalez E, Martin K: Pathogenesis and treatment of renal osteodystrophy. Blood Purif 2003;21:318-326.
41. Kovesdy CP, Kalantar-Zadeh K: Vitamin D receptor activation and survival in chronic kidney disease. Kidney Int 2008;73:1355-1363. (Pubitemid 351770491)
42. Massry SG, Goldstein DA: Role of parathyroid hormone in uremic toxicity. Kidney Int Suppl 1978: S39-S42.
43. Massry SG, Goldstein DA, Malluche HH: Current status of the use of 1, 25 (OH) 2D3 in the management of renal osteodystrophy. Kidney Int 1980;18:409-418.
44. Park JC, Kovesdy CP, Duong U, Streja E, Rambod M, Nissenson AR, Sprague SM, Kalantar-Zadeh K: Association of serum alkaline phosphatase and bone mineral density in maintenance hemodialysis patients. Hemodial Int 2010;14:182-192.
45. Donovan PJ, Propp DA: Calcium and its role in cardiac arrest: understanding the controversy. J Emerg Med 1985;3:105-116.
46. Chavan CB, Sharada K, Rao HB, Narsimhan C: Hypocalcemia as a cause of reversible cardiomyopathy with ventricular tachycardia. Ann Intern Med 2007;146:541-542.
47. Kazmi AS, Wall BM: Reversible congestive heart failure related to profound hypocalcemia secondary to hypoparathyroidism. Am J Med Sci 2007;333:226-229.
48. RuDusky BM: ECG abnormalities associated with hypocalcemia. Chest 2001;119:668-669.
49. McCullough PA: Acute coronary syndromes in patients with renal failure. Curr Cardiol Rep 2003;5:266-270.
50. Young EW, Albert JM, Satayathum S, Goodkin DA, Pisoni RL, Akiba T, Akizawa T, Kurokawa K, Bommer J, Piera L, Port FK: Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. Kidney Int 2005;67:1179-1187.
51. Noordzij M, Boeschoten EW, Bos WJ, Dekker FW, Bossuyt PM, Krediet RT, Korevaar JC: Disturbed mineral metabolism is associated with muscle and skin complaints in a prospective cohort of dialysis patients. Nephrol Dial Transplant 2007;22:2944-2949.
52. Noori N, Kalantar-Zadeh K, Kovesdy CP, Bross R, Benner D, Kopple JD: Association of dietary phosphorus intake and phosphorus to protein ratio with mortality in hemodialysis patients. Clin J Am Soc Nephrol 2010;5:683-692.
53. Kalantar-Zadeh K, Gutekunst L, Mehrotra R, Kovesdy CP, Bross R, Shinaberger CS, Noori N, Hirschberg R, Benner D, Nissenson AR, Kopple JD: Understanding sources of dietary phosphorus in the treatment of patients with chronickidney disease. Clin J Am Soc Nephrol 2010;5:519-530.
54. Dukkipati R, Kovesdy CP, Colman S, Budoff MJ, Nissenson AR, Sprague SM, Kopple JD, Kalantar-Zadeh K: Association of relatively low serum parathyroid hormone with malnutrition-inflammation complex and survival in maintenance hemodialysis patients. J Ren Nutr 2010;20:243-254.